Burning Mouth Syndrome

A group of painful oral symptoms associated with a burning or similar sensation. There is usually a significant organic component with a degree of functional overlay; it is not limited to the psychophysiologic group of disorders.

Drugs by status

Phase 4 trials (4)

clonazepam
alpha-lipoic acid
magnesium trisilicate
dexamethasone

Phase 3 trials (7)

paroxetine
citalopram
duloxetine
escitalopram
sertraline
vortioxetine
pregabalin

Phase 2 trials (3)

thalidomide
rimabotulinumtoxinB
sodium chloride

Phase 1 trials (3)

vitamin e
riboflavin
oryzanol

Other trials (11)

melatonin
acetylcysteine
urea
capsaicin
nalbuphine
caffeine
diazepam
naloxone
b multivitamins
lactobacillus reuteri
qingre liangkou ningxin fang

Organizations

Organization Involved with Phase 4 Indications (2)

University of Alberta
National Autonomous University of Mexico

Organization Involved with Phase 2 Indications (4)

National Institute of Dental and Craniofacial Research (NIDCR)
University of Padova
University of Catania
Carlo Besta Neurological Institute

Organization Involved with Phase 1 Indications (5)

University of Zagreb
Zhejiang Chinese Medical University
Zhejiang University
Guiyang Hospital of Stomatology
Stomatological Hospital of Guiyang

Organization Involved with Other Experimental Indications (7)

Chang Gung University
Universidad de Murcia
University of Milan
University of California, San Francisco
National Taiwan University
University of Sao Paulo
Government of Taiwan